deaths (OS)

laNSCLC - M - all population locally advanced NSCLC - maintenance (M) laNSCLC - M - all population

versus placebo
durvalumab alone vs. placebo 1 0.68 [0.47; 0.99], 1 RCT, I2=0% conclusive
unassessable degree of certainty